Origin is a privately-held, clinical-stage biotechnology company developing a medical technology to deliver therapeutic molecules.
Origin has raised $51K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
Origin's investors include Techstars.
Origin is headquartered in Princeton, United States.
Origin is a privately-held, clinical-stage biotechnology company developing a medical technology to deliver therapeutic molecules.
Origin is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Origin — Funding & Investors." VCBacked, October 17, 2023, https://www.vcbacked.co/company/origin-princeton. Accessed October 21, 2026.
VCBacked. (2023). Origin — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/origin-princeton
{{cite web |title=Origin — Funding & Investors |url=https://www.vcbacked.co/company/origin-princeton |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated